NextBioMedical Co

NextBioMedical Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of NextBioMedical Co (389650.KQ) as of Nov 20, 2026 is -719.54 M KRW. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 1.59 B KRW — a change of -145.22% (lower).

EBITDA

-719.54 MKRW

YoY

-145.22%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of NextBioMedical Co is 2025 -719.54 M KRW. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of NextBioMedical Co was 2024 1.59 B KRW. It decreases by -145.22% lower compared to the previous year.

The NextBioMedical Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2021
-6.97 B KRW
Jan 1, 2022
-4.76 B KRW
Jan 1, 2023
-7.57 B KRW
Jan 1, 2024
1.59 B KRW
Jan 1, 2025
-719.54 M KRW
The NextBioMedical Co EBITDA history
YEAREBITDAYoY
-719.54 MKRW-145.22%
1.59 BKRW-121.03%
-7.57 BKRW+58.95%
-4.76 BKRW-31.70%
-6.97 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NextBioMedical Co Stock analysis

What does NextBioMedical Co do? NextBioMedical Co Ltd generates revenue through the manufacturing and sales of medical equipment, including endoscopic hemostatic agents and vascular embolic microspheres. The company focuses on research and development within the health care equipment and supplies sector, targeting healthcare providers and medical institutions that require specialized equipment for procedures such as endoscopy and vascular interventions. Its products are designed to address specific clinical needs, supporting both diagnostic and therapeutic applications in medical settings. The company operates in the Health Care Equipment & Supplies industry, with a primary focus on Korea-based manufacturing and sales. Its product portfolio includes endoscopic hemostatic agents, which are used to control bleeding during endoscopic procedures, and vascular embolic microspheres, utilized in embolization treatments for vascular conditions. These products are sold to hospitals and medical facilities that require advanced medical solutions for patient care. NextBioMedical Co Ltd's business model relies on the consistent demand for specialized medical equipment in the healthcare sector. By developing and commercializing products such as endoscopic hemostatic agents and vascular embolic microspheres, the company serves healthcare providers seeking reliable and innovative tools for minimally invasive procedures. The company's research and development efforts aim to enhance product efficacy and expand its market presence within the medical equipment industry. NextBioMedical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NextBioMedical Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of NextBioMedical Co is -719.54 M KRW in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of NextBioMedical Co changed from 1.59 B KRW to -719.54 M KRW, representing a -145.22% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) NextBioMedical Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s NextBioMedical Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — NextBioMedical Co

All Key Metrics — NextBioMedical Co